BCKDK gain significantly promoted the proliferation and migration ex vivo, whereas knocked down expression of BCKDK in HO8910-PM OC cells reduced the proliferation and migration ex vivo and inhibited the tumor growth in vivo. The gene discussed is BCKDK; the disease is neoplasm.